Low-dose radiation with immunotherapy for stomach and colon cancer in the abdomen
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a new treatment for stomach or colon cancer that has spread to the lining of the abdomen. It combines low-dose radiation with a type of immunotherapy called NIPS to help your body fight the cancer. The goal is to see if this combination can shrink the tumors and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have stomach or colon cancer that has spread to the lining of the abdomen (confirmed by biopsy or surgery).
- You are generally able to care for yourself (ECOG performance status 2 or less).
- You have at least one tumor that can be measured on a scan and is within the area to be treated with radiation.
- Your heart, liver, kidneys, and blood counts are within acceptable ranges (you will have tests to check these).
- You have not had another cancer in the last 5 years, except for certain non-serious skin cancers or early-stage cervical or bladder cancer.
- You are not pregnant or breastfeeding, and you do not have a severe active infection or a weakened immune system (like HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation, chemotherapy, and immunotherapy for people with colorectal cancer that has spread only to the liver. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests a new sequence of treatments for advanced stomach cancer that has spread to the lining of the abdomen. You would first get low-dose radiation, then a combination of immunotherapy, chemotherapy, and a special type of chemotherapy delivered directly into the belly, to see if it can control the cancer and improve quality of life.
This trial tests whether giving low-dose radiation to liver tumors along with immunotherapy can help people with certain advanced cancers that have spread to the liver. It may improve how well the treatment works for people whose cancer has stopped responding to earlier treatments.
This trial tests a combination of low-dose radiation to the intestines and immunotherapy for people whose cancer has stopped responding to standard treatments including immunotherapy. It may offer a new option when other therapies have failed.
This trial tests a combination of low-dose radiation, chemotherapy, and an immunotherapy drug (PD-1 inhibitor) for people with a specific type of high-risk colon cancer that has not spread. The goal is to see if this approach can shrink the tumor before surgery and improve outcomes.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
Hear when a new LDRT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.